Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model

Design and Synthesis of Bis-Biotin-Containing Reagents for Applications Utilizing Monoclonal Antibody-Based Pretargeting Systems with Streptavidin Mutants

(2010) D. Scott Wilbur et al.   BIOCONJUGATE CHEMISTRY

Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease

(2010) S. I. Park et al.   BLOOD

Bismuth-213 radioimmunotherapy with C595 anti–MUC1 monoclonal antibody in an ovarian cancer ascites model

(2010) Emma Y. Song et al.   CANCER BIOLOGY & THERAPY

The  -Camera: A Quantitative Digital Autoradiography Technique Using a Charge-Coupled Device for Ex Vivo High-Resolution Bioimaging of  -Particles

(2010) T. Back et al.   JOURNAL OF NUCLEAR MEDICINE

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

(2009) J. M. Pagel et al.   BLOOD

Glomerular Filtration Rate After Alpha-Radioimmunotherapy with 211At-MX35-F(ab′)2: A Long-Term Study of Renal Function in Nude Mice

(2009) Tom Bäck et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia

(2008) J. M. Pagel et al.   CANCER RESEARCH

Radioimmunotherapeutic approaches for leukemia: the past, present and future

(2008) J.M. Pagel   CYTOTHERAPY